메뉴 건너뛰기
Diabetologia
Volumn 57, Issue 12, 2014, Pages 2599-2602
Characterisation of glomerular haemodynamic responses to SGLT2 inhibition in patients with type 1 diabetes and renal hyperfiltration
Author keywords

Diabetes; Renal hyperfiltration; SGLT2 inhibition
Indexed keywords

SODIUM GLUCOSE COTRANSPORTER 2; ANTIDIABETIC AGENT; BENZHYDRYL DERIVATIVE; EMPAGLIFLOZIN; GLUCOSIDE; SLC5A2 PROTEIN, HUMAN;
EID: 84933523949     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-014-3396-4     Document Type: Letter
Times cited : (135)
References (10)
  • 1
    • 0020041880 scopus 로고
    • The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies
    • Hostetter TH, Rennke HG, Brenner BM (1982) The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies. Am J Med 72:375–380
    • (1982) Am J Med , vol.72 , pp. 375-380
    • Hostetter, T.H.1    Rennke, H.G.2    Brenner, B.M.3
  • 2
    • 0001704334 scopus 로고
    • Evaluation of renal resistances, with special reference to changes in essential hypertension
    • Gomez DM (1951) Evaluation of renal resistances, with special reference to changes in essential hypertension. J Clin Invest 30:1143–1155
    • (1951) J Clin Invest , vol.30 , pp. 1143-1155
    • Gomez, D.M.1
  • 3
    • 84893214045 scopus 로고    scopus 로고
    • Renal hemodynamic effect of sodium-glucose cotransporter 2 inhibition in patients with type 1 diabetes mellitus
    • Cherney DZI, Perkins BA, Soleymanlou N et al (2014) Renal hemodynamic effect of sodium-glucose cotransporter 2 inhibition in patients with type 1 diabetes mellitus. Circulation 129:587–597
    • (2014) Circulation , vol.129 , pp. 587-597
    • Cherney, D.Z.I.1    Perkins, B.A.2    Soleymanlou, N.3
  • 4
    • 84892959743 scopus 로고    scopus 로고
    • The effect of empagliflozin on arterial stiffness and heart rate variability in subjects with uncomplicated type 1 diabetes mellitus
    • Cherney DZ, Perkins BA, Soleymanlou N et al (2014) The effect of empagliflozin on arterial stiffness and heart rate variability in subjects with uncomplicated type 1 diabetes mellitus. Cardiovasc Diabetol 13:28
    • (2014) Cardiovasc Diabetol , vol.13 , pp. 28
    • Cherney, D.Z.1    Perkins, B.A.2    Soleymanlou, N.3
  • 5
    • 84899105421 scopus 로고    scopus 로고
    • Sodium-glucose cotransporter 2 inhibition and glycemic control in type 1 diabetes: results of an 8-week open-label proof-of-concept trial
    • Perkins BA, Cherney DZ, Partridge H et al (2014) Sodium-glucose cotransporter 2 inhibition and glycemic control in type 1 diabetes: results of an 8-week open-label proof-of-concept trial. Diabetes Care 37:1480–1483
    • (2014) Diabetes Care , vol.37 , pp. 1480-1483
    • Perkins, B.A.1    Cherney, D.Z.2    Partridge, H.3
  • 6
    • 0032707179 scopus 로고    scopus 로고
    • Glomerular hyperfiltration in experimental diabetes mellitus: potential role of tubular reabsorption
    • Vallon V, Richter K, Blantz RC, Thomson S, Osswald H (1999) Glomerular hyperfiltration in experimental diabetes mellitus: potential role of tubular reabsorption. J Am Soc Nephrol 10:2569–2576
    • (1999) J Am Soc Nephrol , vol.10 , pp. 2569-2576
    • Vallon, V.1    Richter, K.2    Blantz, R.C.3    Thomson, S.4    Osswald, H.5
  • 7
    • 0035988195 scopus 로고    scopus 로고
    • Short-term moderate sodium restriction induces relative hyperfiltration in normotensive normoalbuminuric type I diabetes mellitus
    • Luik PT, Hoogenberg K, van Der Kleij FG et al (2002) Short-term moderate sodium restriction induces relative hyperfiltration in normotensive normoalbuminuric type I diabetes mellitus. Diabetologia 45:535–541
    • (2002) Diabetologia , vol.45 , pp. 535-541
    • Luik, P.T.1    Hoogenberg, K.2    van Der Kleij, F.G.3
  • 8
    • 42049107348 scopus 로고    scopus 로고
    • Telmisartan, ramipril, or both in patients at high risk for vascular events
    • Investigators O, Yusuf S, Teo KK et al (2008) Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 358:1547–1559
    • (2008) N Engl J Med , vol.358 , pp. 1547-1559
    • Investigators, O.1    Yusuf, S.2    Teo, K.K.3
  • 9
    • 84869492851 scopus 로고    scopus 로고
    • Cardiorenal end points in a trial of aliskiren for type 2 diabetes
    • Parving H-H, Brenner BM, McMurray JJV et al (2012) Cardiorenal end points in a trial of aliskiren for type 2 diabetes. N Engl J Med 367:2204–2213
    • (2012) N Engl J Med , vol.367 , pp. 2204-2213
    • Parving, H.-H.1    Brenner, B.M.2    McMurray, J.J.V.3
  • 10
    • 84887467090 scopus 로고    scopus 로고
    • Combined angiotensin inhibition for the treatment of diabetic nephropathy
    • Fried LF, Emanuele N, Zhang JH et al (2013) Combined angiotensin inhibition for the treatment of diabetic nephropathy. N Engl J Med 369:1892–1903
    • (2013) N Engl J Med , vol.369 , pp. 1892-1903
    • Fried, L.F.1    Emanuele, N.2    Zhang, J.H.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.